Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

The matrix metalloproteinases (MMPs) form an enzyme family of which gelatinase B (MMP-9) represents the largest and most complex member. We focus here on the biochemical properties, regulation, and functions of gelatinase B. The tight regulation of gelatinase B activity is highly complex and is established at five different levels. The transcription of the gelatinase B-gene depends on various cis-elements in its gene promotor and is induced or repressed by a large variety of soluble factors, including cytokines, growth factors, and hormones and by cellular contacts acting through specific signaling pathways. The specific regulation of its secretion occurs in cells storing gelatinase B in granules. After secretion, progelatinase B must be activated through an activation network. The enzyme activity is further regulated by inhibition and by other mechanisms, such as fine-tuning and stabilization by glycosylation. The ability of gelatinase B to degrade components of the extracellular matrix and to regulate the activity of a number of soluble proteins confers an important role in various physiological and pathological processes. These include reproduction, growth, development, inflammation, and vascular and proliferative diseases.

[1]  T. Putti,et al.  The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer , 2004, Cancer Research.

[2]  S. Saad,et al.  Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts , 2000, Breast Cancer Research and Treatment.

[3]  R. Suzuki,et al.  Experimental metastasis is suppressed in MMP-9-deficient mice , 1999, Clinical & Experimental Metastasis.

[4]  Gurmit Singh,et al.  Transforming growth factor β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells , 1999, Clinical and Experimental Metastasis.

[5]  R. Muschel,et al.  Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat , 1998, Clinical & Experimental Metastasis.

[6]  Y. Okada,et al.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and β2-microglobulin amyloidosis , 1996, Virchows Archiv.

[7]  R. Reich,et al.  Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells , 1995, Clinical & Experimental Metastasis.

[8]  T. Miyatake,et al.  Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE) , 1988, Neurochemical Research.

[9]  F. Kikkawa,et al.  Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells , 2004, Clinical & Experimental Metastasis.

[10]  W. Yung,et al.  Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades , 2004, Clinical & Experimental Metastasis.

[11]  L. Liotta,et al.  Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas , 2004, Clinical & Experimental Metastasis.

[12]  方福德 构成性表达(constitutive expression) , 2003 .

[13]  R. Rey Regulation of spermatogenesis. , 2003, Endocrine development.

[14]  A. Goris,et al.  Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis , 2002, Journal of the Neurological Sciences.

[15]  G. Opdenakker,et al.  Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.

[16]  C. Janson,et al.  Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. , 2002, Acta crystallographica. Section D, Biological crystallography.

[17]  W. Bao,et al.  Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. , 2002, Cardiovascular research.

[18]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[19]  A. Henney,et al.  Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. , 2002, Journal of molecular biology.

[20]  D. Devine,et al.  Mannose-binding Lectin (MBL) Mutants Are Susceptible to Matrix Metalloproteinase Proteolysis , 2002, The Journal of Biological Chemistry.

[21]  B. Marmer,et al.  Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide* , 2002, The Journal of Biological Chemistry.

[22]  R. Romero,et al.  A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. , 2002, Molecular human reproduction.

[23]  Pauline M Rudd,et al.  An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. , 2002, Analytical biochemistry.

[24]  F. Luscinskas,et al.  Neutrophils from MMP‐9‐ or neutrophil elastase‐deficient mice show no defect in transendothelial migration under flow in vitro , 2002, Journal of leukocyte biology.

[25]  G. Schuler,et al.  Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.

[26]  A. Mantovani,et al.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Tsilibary,et al.  Effects of collagen IV on neuroblastoma cell matrix-related functions. , 2002, Experimental cell research.

[28]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[29]  W. Fan,et al.  Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[30]  Yong Jiang,et al.  Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. , 2002, Cancer research.

[31]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[32]  P. E. Van den Steen,et al.  Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Takashi Sato,et al.  Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma , 2002, Cancer research.

[34]  G. Rice,et al.  Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade , 2002 .

[35]  R. Mecham,et al.  Processing of Type II Procollagen Amino Propeptide by Matrix Metalloproteinases* , 2002, The Journal of Biological Chemistry.

[36]  T. Ikebe,et al.  The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer. , 2002, Biochimica et biophysica acta.

[37]  G. Opdenakker,et al.  Regulation of gelatinase B in human monocytic and endothelial cells by PECAM‐1 ligation and its modulation by interferon‐beta , 2002, Journal of leukocyte biology.

[38]  R L Juliano,et al.  Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. , 2002, Annual review of pharmacology and toxicology.

[39]  G. Rice,et al.  Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen‐dependent matrix degradation in ovarian cancer , 2002 .

[40]  G. Rice,et al.  Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. , 2002, Journal of cellular biochemistry.

[41]  G. Rice,et al.  Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. , 2002, Carcinogenesis.

[42]  T. Keck,et al.  Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. , 2002, Gastroenterology.

[43]  S. Silbiger,et al.  Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. , 2002, American journal of physiology. Renal physiology.

[44]  C. Overall,et al.  Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. , 2002, Cancer research.

[45]  P. Plinkert,et al.  The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. , 2001, Experimental cell research.

[46]  Jun Yao,et al.  Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells , 2001, Oncogene.

[47]  S. Rennard,et al.  Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. , 2001, The Journal of allergy and clinical immunology.

[48]  R. V. Sharma,et al.  Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. , 2001, American journal of physiology. Heart and circulatory physiology.

[49]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[50]  M. Mosunjac,et al.  Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. , 2001, AIDS research and human retroviruses.

[51]  A. Burgess,et al.  Regulation of Transforming Growth Factor-β Signaling , 2001 .

[52]  E. Benveniste,et al.  Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-γ and IFN-β: Critical Role of STAT-1α1 , 2001, The Journal of Immunology.

[53]  M. Morgan,et al.  Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines , 2001, Molecular carcinogenesis.

[54]  S. Itohara,et al.  Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy , 2001, Nature Medicine.

[55]  C. Munaut,et al.  Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[56]  S. Grässel,et al.  Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). , 2001, Journal of cell science.

[57]  M. Sittinger,et al.  Secretion of Gelatinases and Activation of Gelatinase A (MMP-2) by Human Rheumatoid Synovial Fibroblasts , 2001, Biological chemistry.

[58]  R. Dwek,et al.  Matrix remodelling enzymes, the protease cascade and glycosylation. , 2001, Biochimica et biophysica acta.

[59]  K. Isshiki,et al.  Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. , 2001, Kidney international.

[60]  P. E. Van den Steen,et al.  Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.

[61]  R. Hershkoviz,et al.  Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-α1 , 2001, The Journal of Immunology.

[62]  C. Wolf‐Peeters,et al.  Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. , 2001, The American journal of pathology.

[63]  S. Davidge,et al.  Matrix metalloproteinases regulate neutrophil‐endothelial cell adhesion through generation of endothelin‐1[1–32] , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  J. Sleeman,et al.  CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. , 2001, Journal of cell science.

[65]  D. Schlaepfer,et al.  Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.

[66]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[67]  M Stürzl,et al.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. , 2001, Molecular biology of the cell.

[68]  S. Itohara,et al.  Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia , 2001, Neuroreport.

[69]  A. Weyrich,et al.  Differential Regulation of Matrix Metalloproteinase-9 by Monocytes Adherent to Collagen and Platelets , 2001, Circulation research.

[70]  Y. Jiang,et al.  Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. , 2001, Biochemical and biophysical research communications.

[71]  S. Ye,et al.  Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage , 2001, Stroke.

[72]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[73]  R. V. Sharma,et al.  Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. , 2001, Journal of applied physiology.

[74]  T. Lehtimäki,et al.  Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[75]  G. Bancroft,et al.  Production of Matrix Metalloproteinases in Response to Mycobacterial Infection , 2001, Infection and Immunity.

[76]  H. Duan,et al.  v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. , 2001, Free radical biology & medicine.

[77]  R. Fridman,et al.  Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.

[78]  D. Missé,et al.  HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. , 2001, Blood.

[79]  D. Argyle,et al.  Molecular cloning and characterization of canine metalloproteinase-9 gene promoter. , 2001, Gene.

[80]  M. Stack,et al.  Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase Activity* , 2001, The Journal of Biological Chemistry.

[81]  R. Kiss,et al.  Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[82]  Takashi Kobayashi,et al.  A novel mechanism of matrix metalloproteinase‐9 gene expression implies a role for keratinization , 2001, EMBO reports.

[83]  H. Matsuda,et al.  Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. , 2001, The Journal of veterinary medical science.

[84]  M. Padrines,et al.  Potential synergies between matrix proteins and soluble factors on resorption and proteinase activities of rabbit bone cells. , 2001, Histology and histopathology.

[85]  L. Zhuang,et al.  Effects of Matrix Proteins on the Expression of Matrix Metalloproteinase-2, -9, and -14 and Tissue Inhibitors of Metalloproteinases in Human Cytotrophoblast Cells During the First Trimester1 , 2001, Biology of reproduction.

[86]  V. Wee Yong,et al.  Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.

[87]  Y. Suh,et al.  Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1* , 2001, The Journal of Biological Chemistry.

[88]  P. Tsao,et al.  Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. , 2001, Circulation research.

[89]  J W Smith,et al.  Substrate Hydrolysis by Matrix Metalloproteinase-9* , 2001, The Journal of Biological Chemistry.

[90]  A. Newby,et al.  Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. , 2001, Cardiovascular research.

[91]  Inge Nelissen,et al.  Gelatinase B functions as regulator and effector in leukocyte biology , 2001, Journal of leukocyte biology.

[92]  P. Speight,et al.  αvβ6integrin promotes invasion of squamous carcinoma cells through up‐regulation of matrix metalloproteinase‐9 , 2001 .

[93]  P. Speight,et al.  αvβ6 Integrin Upregulates Matrix Metalloproteinase 9 and Promotes Migration of Normal Oral Keratinocytes , 2001 .

[94]  M. Díaz-Guerra,et al.  Expression of cyclooxygenase‐2 promotes the release of matrix metalloproteinase‐2 and ‐9 in fetal rat hepatocytes , 2001, Hepatology.

[95]  J. Tonn,et al.  Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules , 2001, Journal of neuropathology and experimental neurology.

[96]  D. Collen,et al.  Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity. , 2001, Thrombosis research.

[97]  H. Tschesche,et al.  The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. , 2001, European journal of biochemistry.

[98]  G. Giannelli,et al.  Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion , 2001, Laboratory Investigation.

[99]  A. Sala,et al.  Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia , 2001, The Journal of Neuroscience.

[100]  D. Greaves,et al.  Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene , 2001, The Journal of Biological Chemistry.

[101]  M. Stack,et al.  Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. , 2001, Cancer research.

[102]  J. Sun,et al.  Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. , 2001, Cancer research.

[103]  J. Michel,et al.  Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. , 2001, Cardiovascular Research.

[104]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[105]  D. Crowe,et al.  Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. , 2001, International journal of oncology.

[106]  G. Striker,et al.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.

[107]  D. Ribatti,et al.  Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. , 2001, Life sciences.

[108]  A. Komiyama,et al.  Prostacyclin Inhibits the Production of MMP-9 Induced by Phorbol Ester through Protein Kinase A Activation, but Does Not Affect the Production of MMP-2 in Human Cultured Mesangial Cells , 2001, Kidney and Blood Pressure Research.

[109]  J. Heino,et al.  Three-dimensional collagen regulates collagen gene expression by a mechanism that requires serine/threonine kinases and is independent of mechanical contraction. , 2001, Biochemical and biophysical research communications.

[110]  Gyeong-Moon Kim,et al.  Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.

[111]  W. Garner,et al.  Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. , 2001, The Journal of biological chemistry.

[112]  A. Burgess,et al.  Regulation of transforming growth factor-beta signaling. , 2001, Molecular cell biology research communications : MCBRC.

[113]  神原 千晶 Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-1-associated myelopathy , 2001 .

[114]  E. Benveniste,et al.  Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. , 2001, Journal of immunology.

[115]  S. Weiss,et al.  Role of stromelysin 1 and gelatinase B in experimental acute lung injury. , 2001, American journal of respiratory cell and molecular biology.

[116]  P. Speight,et al.  alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. , 2001, The Journal of investigative dermatology.

[117]  Y. Nishimura,et al.  Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[118]  D. Crowe,et al.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. , 2001, Neoplasia.

[119]  D. Boyd,et al.  KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. , 2001, The Journal of biological chemistry.

[120]  N. Ahmed,et al.  The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. , 2001, International journal of cancer.

[121]  G. Giannelli,et al.  Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. , 2001, Laboratory investigation; a journal of technical methods and pathology.

[122]  P. Speight,et al.  AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. , 2001, International journal of cancer.

[123]  D. Ribatti,et al.  alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. , 2001, Experimental hematology.

[124]  W. Colucci,et al.  Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. , 2001, American journal of physiology. Cell physiology.

[125]  B. Sheu,et al.  A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.

[126]  R. Dwek,et al.  O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. , 2000, Biochemistry.

[127]  H. Haller,et al.  Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. , 2000, Journal of cell science.

[128]  Raymond Sawaya,et al.  Effects of radiation on the levels of MMP‐2, MMP‐9 and TIMP‐1 during morphogenic glial‐endothelial cell interactions , 2000, International journal of cancer.

[129]  J. Spencer,et al.  Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. , 2000, The American journal of pathology.

[130]  A. Cho,et al.  Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[131]  J. Pfeilschifter,et al.  Amplification of IL-1β-Induced Matrix Metalloproteinase-9 Expression by Superoxide in Rat Glomerular Mesangial Cells Is Mediated by Increased Activities of NF-κB and Activating Protein-1 and Involves Activation of the Mitogen-Activated Protein Kinase Pathways1 , 2000, The Journal of Immunology.

[132]  Donald E. Ingber,et al.  Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. , 2000, Journal of cell science.

[133]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[134]  P. E. Van den Steen,et al.  Structural Characterization of the Catalytic Active Site in the Latent and Active Natural Gelatinase B from Human Neutrophils* , 2000, The Journal of Biological Chemistry.

[135]  S. Chien,et al.  Biomechanical regulation of matrix metalloproteinase‐9 in cultured chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[136]  M. Ratajczak,et al.  Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. , 2000, Experimental hematology.

[137]  M. Jaurand,et al.  Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases , 2000, British Journal of Cancer.

[138]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[139]  P. E. Van den Steen,et al.  Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.

[140]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[141]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[142]  L. Sjulson,et al.  Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration , 2000, Journal of Neuroimmunology.

[143]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.

[144]  S. Shapiro,et al.  Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. , 2000, The Journal of biological chemistry.

[145]  Y. Masuho,et al.  Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP , 2000, FEBS letters.

[146]  F. Higashino,et al.  Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. , 2000, Cancer letters.

[147]  G. Opdenakker,et al.  Gelatinase B deficiency impairs reproduction. , 2000, The Journal of clinical investigation.

[148]  C. López-Otín,et al.  Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. , 2000, Cancer research.

[149]  Z. Werb,et al.  The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.

[150]  R. Hynes,et al.  Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. , 2000, Journal of cell science.

[151]  D. Noonan,et al.  The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity , 2000 .

[152]  T. Betsuyaku,et al.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. , 2000, The American journal of pathology.

[153]  V. Yong,et al.  Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.

[154]  G. Opdenakker,et al.  In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[155]  T. Betsuyaku,et al.  Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. , 2000, The American journal of pathology.

[156]  J. Keiser,et al.  Hepatocyte growth factor enhances MMP activity in human endothelial cells. , 2000, Biochemical and biophysical research communications.

[157]  T. Olsson,et al.  Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis , 2000, Journal of Neuroimmunology.

[158]  M. Horton,et al.  Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[159]  R. Rezzonico,et al.  Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1 (MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes1 , 2000, The Journal of Immunology.

[160]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[161]  G. Stark,et al.  Complex roles of Stat1 in regulating gene expression , 2000, Oncogene.

[162]  A. Ricca,et al.  bcl‐2 over‐expression enhances NF‐κB activity and induces mmp‐9 transcription in human MCF7ADR breast‐cancer cells , 2000, International journal of cancer.

[163]  Bao Q. Pham,et al.  Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B* , 2000, The Journal of Biological Chemistry.

[164]  G. Koh,et al.  Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. , 2000, Biochemical and biophysical research communications.

[165]  J. Lissitzky,et al.  Anti‐β4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP‐2 expression , 2000, International journal of cancer.

[166]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[167]  C. Lafuma,et al.  Induction of Matrix Metalloproteinase MMP‐9 (92‐kDa Gelatinase) by Retinoic Acid in Human Neuroblastoma SKNBE Cells , 2000, Journal of neurochemistry.

[168]  G. Hou,et al.  Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. , 2000, The American journal of pathology.

[169]  G. Fiucci,et al.  Phospholipase D: molecular and cell biology of a novel gene family. , 2000, The Biochemical journal.

[170]  L. Kotra,et al.  Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9 , 2000, The Journal of Biological Chemistry.

[171]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[172]  C. López-Otín,et al.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.

[173]  K. Okazaki,et al.  Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. , 2000, Experimental cell research.

[174]  G. Opdenakker,et al.  Expression of gelatinase B in trachomatous conjunctivitis , 2000, The British journal of ophthalmology.

[175]  J. Pelletier,et al.  Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[176]  D. Noonan,et al.  The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. , 2000, International journal of cancer.

[177]  T. Ugarova,et al.  Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. , 2000, Experimental cell research.

[178]  T. Sato,et al.  A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. , 2000, The Journal of rheumatology.

[179]  K. Harada,et al.  Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structu , 2000, Arthritis and rheumatism.

[180]  J. Pfeilschifter,et al.  Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. , 2000, Kidney international.

[181]  D. Ruiter,et al.  Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. , 2000, International journal of cancer.

[182]  J. Cowland,et al.  The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules , 1999, Journal of leukocyte biology.

[183]  H Yonas,et al.  Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. , 1999, Stroke.

[184]  R. Sciot,et al.  Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. , 1999, The Journal of clinical investigation.

[185]  M. Matsumoto,et al.  Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. , 1999, Journal of immunology.

[186]  D. Lovett,et al.  YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. , 1999, Journal of the American Society of Nephrology : JASN.

[187]  R. V. Sharma,et al.  eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[188]  Y. Itoh,et al.  Membrane Type 4 Matrix Metalloproteinase (MT4-MMP, MMP-17) Is a Glycosylphosphatidylinositol-anchored Proteinase* , 1999, The Journal of Biological Chemistry.

[189]  H. Kuivaniemi,et al.  Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. , 1999, Biochemical and biophysical research communications.

[190]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[191]  A. Henney,et al.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1 , 1999, Human Genetics.

[192]  T. Sharshar,et al.  Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome , 1999, Neurology.

[193]  E. Middleton,et al.  Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis‐associated properties in A431 cells overexpressing epidermal growth factor receptor , 1999, British journal of pharmacology.

[194]  R. Dwek,et al.  Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. , 1999, Biochemistry.

[195]  J. Yagüe,et al.  Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. , 1999, Blood.

[196]  B. Janji,et al.  Autocrine TGF‐β‐regulated expression of adhesion receptors and integrin‐linked kinase in HT‐144 melanoma cells correlates with their metastatic phenotype , 1999, International journal of cancer.

[197]  E. Benveniste,et al.  The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells* , 1999, The Journal of Biological Chemistry.

[198]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[199]  Z. Werb,et al.  Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.

[200]  F. Berditchevski,et al.  Function of α3β1–Tetraspanin Protein Complexes in Tumor Cell Invasion. Evidence for the Role of the Complexes in Production of Matrix Metalloproteinase 2 (Mmp-2) , 1999, The Journal of cell biology.

[201]  R. Willemze,et al.  Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[202]  T. Seifert,et al.  Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis , 1999, Journal of Neuroimmunology.

[203]  F Ghezzi,et al.  Matrix metalloproteinases-9 in preterm and term human parturition. , 1999, The Journal of maternal-fetal medicine.

[204]  K. Conant,et al.  Cerebrospinal fluid levels of MMP‐2, 7, and 9 are elevated in association with human immunodeficiency virus dementia , 1999, Annals of neurology.

[205]  R. Pereira,et al.  Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. , 1999, American journal of physiology. Endocrinology and metabolism.

[206]  M. Fujimura,et al.  Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[207]  P. Grammas,et al.  Gelatinase A expression in endothelial cells is regulated by at least two cis-acting promoter elements. , 1999, Biochimica et biophysica acta.

[208]  L. Zheng,et al.  Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[209]  M. Hoshino,et al.  Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.

[210]  Z. Galis,et al.  Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. , 1999, Experimental and molecular pathology.

[211]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[212]  James Varani,et al.  Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor‐stimulated human epidermal keratinocytes , 1999, Journal of cellular physiology.

[213]  M. Hendrix,et al.  Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. , 1999, Cancer research.

[214]  T. Seifert,et al.  Differential expression of matrix metalloproteinases in bacterial meningitis. , 1999, Brain : a journal of neurology.

[215]  C. Legrand,et al.  Airway Epithelial Cell Migration Dynamics , 1999, The Journal of cell biology.

[216]  Y. Sasaguri,et al.  Shortened microsatellite d(CA)21 sequence down‐regulates promoter activity of matrix metalloproteinase 9 gene , 1999, FEBS letters.

[217]  P. Fuhr,et al.  Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy , 1999, Neurology.

[218]  G. Opdenakker,et al.  Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins , 1999, Glia.

[219]  C. P. Leblond,et al.  Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[220]  C. Flaitz,et al.  PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma , 1999, British Journal of Cancer.

[221]  Hiroki Sato,et al.  Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.

[222]  B. Dahlén,et al.  Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma , 1999, Thorax.

[223]  J. Mudgett,et al.  Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[224]  G. Schneider,et al.  Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.

[225]  P. Kivisäkk,et al.  Metalloproteinases and their tissue inhibitors in multiple sclerosis. , 1999, Journal of autoimmunity.

[226]  C. López-Otín,et al.  Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. , 1999, Cancer research.

[227]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[228]  D. Faller,et al.  Feline Leukemia Virus Long Terminal Repeat Activates Collagenase IV Gene Expression through AP-1 , 1999, Journal of Virology.

[229]  M. d’Ortho,et al.  Balance between MMP‐9 and TIMP‐1 Expressed by Human Bronchial Epithelial Cells: Relevance to Asthma , 1999, Annals of the New York Academy of Sciences.

[230]  P. Nelson,et al.  Chemokine‐Induced Extravasation of MonoMac 6 Cells: Chemotaxis and MMP Activity , 1999, Annals of the New York Academy of Sciences.

[231]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[232]  M. Selman,et al.  Expression and Localization of TIMP‐1, TIMP‐2, MMP‐13, MMP‐2, and MMP‐9 in Early and Advanced Experimental Lung Silicosis , 1999, Annals of the New York Academy of Sciences.

[233]  M. Nakajima,et al.  Retinoic acid synergizes with cyclic AMP to enhance MMP-2 basal promoter activity. , 1999, Biochemical and biophysical research communications.

[234]  J. Rozmus,et al.  Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. , 1999, Blood.

[235]  H. Nishigori,et al.  ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. , 1999, Life sciences.

[236]  T. Tuan,et al.  Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase‐B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[237]  P. Carmeliet,et al.  Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice , 1999, Thrombosis and Haemostasis.

[238]  R. Willemze,et al.  Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8. , 1999, Current opinion in hematology.

[239]  A. Zalewski,et al.  Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[240]  J. Weitzman,et al.  Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. , 1999, Journal of Cell Science.

[241]  F. Balkwill,et al.  MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts , 1999, British Journal of Cancer.

[242]  A. Gulino,et al.  Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[243]  G. Butler,et al.  Human Tissue Inhibitor of Metalloproteinases 3 Interacts with Both the N- and C-terminal Domains of Gelatinases A and B , 1999, The Journal of Biological Chemistry.

[244]  A. Evans,et al.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.

[245]  D. Fishman,et al.  Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. , 1999, Cancer research.

[246]  C. Figdor,et al.  Biology of IL‐8‐Induced Stem Cell Mobilization , 1999, Annals of the New York Academy of Sciences.

[247]  I. Thesleff,et al.  Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis. , 1999, European journal of oral sciences.

[248]  R. Johnston,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0291 , 2022 .

[249]  T. Chard,et al.  Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. , 1999, Molecular human reproduction.

[250]  P. Ruck,et al.  Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. , 1999, Human reproduction.

[251]  C. Meldrum,et al.  The αvβ6 integrin induces gelatinase B secretion in colon cancer cells , 1999 .

[252]  Quan Zhao,et al.  Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.

[253]  S. Kaul,et al.  Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. , 1999, Circulation.

[254]  A. Glasier,et al.  Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. , 1999, Human reproduction.

[255]  L. Hudson,et al.  Sustained Activation of the Mitogen-activated Protein Kinase Pathway , 1999, The Journal of Biological Chemistry.

[256]  W. Sanger,et al.  Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. , 1999, International Journal of Oncology.

[257]  M. Cuzner,et al.  Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.

[258]  T. Thompson,et al.  Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. , 1999, Molecular biology of the cell.

[259]  J. Palace,et al.  Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. , 1999, Brain : a journal of neurology.

[260]  K. Tanabe,et al.  Involvement of CD44 in matrix metalloproteinase‐2 regulation in human melanoma cells , 1999, International journal of cancer.

[261]  Everts,et al.  CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts , 1999, Clinical and experimental immunology.

[262]  T. Betsuyaku,et al.  Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.

[263]  T. Betsuyaku,et al.  Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. , 1999, American journal of respiratory cell and molecular biology.

[264]  T. Betsuyaku,et al.  Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury. , 1999, Chest.

[265]  T. Ny,et al.  Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. , 1999, Endocrinology.

[266]  F. Lee,et al.  Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. , 1999, The Journal of biological chemistry.

[267]  B. Coomber,et al.  Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells In vitro. , 1999, Biology of reproduction.

[268]  I. Stamenkovic,et al.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.

[269]  C. Meldrum,et al.  The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. , 1999, International journal of cancer.

[270]  A. Kugler Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.

[271]  B. Aggarwal,et al.  Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. , 1999, FEBS letters.

[272]  P. Courtoy,et al.  Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. , 1999, European journal of biochemistry.

[273]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[274]  H. Larjava,et al.  MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? , 1998, Biochemical and biophysical research communications.

[275]  R. Pierce,et al.  Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.

[276]  Y. Sun,et al.  Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. , 1998, Journal of immunology.

[277]  D. Lovett,et al.  A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription* , 1998, The Journal of Biological Chemistry.

[278]  P. Koolwijk,et al.  A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[279]  L. Kappos,et al.  Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. , 1998, Brain : a journal of neurology.

[280]  D. Crowe,et al.  alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. , 1998, International journal of oncology.

[281]  R. Dwek,et al.  Oligosaccharides of recombinant mouse gelatinase B variants. , 1998, Biochimica et biophysica acta.

[282]  G. Murray,et al.  Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. , 1998, European journal of biochemistry.

[283]  R. Clark,et al.  The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[284]  Z. Shao,et al.  Genistein exerts multiple suppressive effects on human breast carcinoma cells. , 1998, Cancer research.

[285]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[286]  P. Libby,et al.  Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.

[287]  A. Eisen,et al.  Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[288]  T. Thompson,et al.  Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines. , 1998, Cancer research.

[289]  S. Lorenzl,et al.  Matrix metalloproteinases contribute to the blood—brain barrier disruption during bacterial meningitis , 1998, Annals of neurology.

[290]  L. Wahl,et al.  Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.

[291]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[292]  M. d’Ortho,et al.  The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. , 1998, Journal of cell science.

[293]  A. Newby,et al.  Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB , 1998, FEBS letters.

[294]  F. Goebel,et al.  Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. , 1998, The Journal of infectious diseases.

[295]  M. Quintanilla,et al.  Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[296]  L. Feng,et al.  Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[297]  Y. Okada,et al.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. , 1998, Journal of neuropathology and experimental neurology.

[298]  Q. Sang,et al.  Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.

[299]  J. Sznajder,et al.  Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. , 1998, The American journal of pathology.

[300]  H. Takeuchi,et al.  Involvement of proteasomes in migration and matrix metalloproteinase‐9 production of oral squamous cell carcinoma , 1998, International journal of cancer.

[301]  F. Morel,et al.  Human B Lymphocytes Synthesize the 92-kDa Gelatinase, Matrix Metalloproteinase-9* , 1998, The Journal of Biological Chemistry.

[302]  C. Overall,et al.  The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation* , 1998, The Journal of Biological Chemistry.

[303]  Z. Werb,et al.  Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid , 1998, The Journal of experimental medicine.

[304]  U. Shankavaram,et al.  Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2 , 1998, Journal of leukocyte biology.

[305]  L. Hudson,et al.  Epidermal growth factor (EGF)‐ and scatter factor/hepatocyte growth factor (SF/HGF)‐mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)‐9 , 1998, Journal of cellular physiology.

[306]  V. Kähäri,et al.  Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[307]  S. Maśliński,et al.  Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils , 1998, Inflammation Research.

[308]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[309]  T. Nishikawa,et al.  Differential Regulation of MMP-2 and MMP-9 Gelatinases in Cultured Human Keratinocytes , 1998, Dermatology.

[310]  T. Kobayashi,et al.  A Case of Anaphylactoid Purpura with Multiple Blister Formation: Possible Pathophysiological Role of Gelatinase (MMP-9) , 1998, Dermatology.

[311]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[312]  Z. Galis,et al.  N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? , 1998, Circulation.

[313]  C. Confavreux,et al.  Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV‐1 infected patients with tropical spastic paraparesis , 1998, Neurology.

[314]  G. Opdenakker,et al.  Gelatinase B in proliferative vitreoretinal disorders. , 1998, American journal of ophthalmology.

[315]  A. Harf,et al.  Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells. , 1998, American journal of respiratory cell and molecular biology.

[316]  Raymond Sawaya,et al.  Induction of Matrix Metalloproteinase-9 Requires a Polymerized Actin Cytoskeleton in Human Malignant Glioma Cells* , 1998, The Journal of Biological Chemistry.

[317]  Y. St-Pierre,et al.  In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. , 1998, Biochimica et biophysica acta.

[318]  E. Huberman,et al.  Fibronectin-mediated Cell Adhesion Is Required for Induction of 92-kDa Type IV Collagenase/Gelatinase (MMP-9) Gene Expression during Macrophage Differentiation , 1998, The Journal of Biological Chemistry.

[319]  G. Opdenakker,et al.  Regulation of gelatinase B (MMP‐9) in leukocytes by plant lectins , 1998, FEBS letters.

[320]  G. Rosenberg,et al.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[321]  T. Haas,et al.  Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. , 1998, The Journal of biological chemistry.

[322]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[323]  R. Fridman,et al.  High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV* , 1998, The Journal of Biological Chemistry.

[324]  H. Pfister,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid , 1998, Journal of Neuroimmunology.

[325]  H. Hartung,et al.  Matrix metalloproteinases MMP‐9 and MMP‐7 are expressed in experimental autoimmune neuritis and the guillain‐barré syndrome , 1998, Annals of neurology.

[326]  E. Ohuchi,et al.  Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. , 1998, European journal of biochemistry.

[327]  B. Morrey,et al.  Histologic and biochemical differences between osteolytic and nonosteolytic membranes around femoral components of an uncemented total hip arthroplasty. , 1998, The Journal of arthroplasty.

[328]  A. Galloway,et al.  Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. , 1998, The Journal of surgical research.

[329]  F. Aoudjit,et al.  Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. , 1998, Journal of immunology.

[330]  D. Boyd,et al.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.

[331]  W. Scherbaum,et al.  mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. , 1998, Thyroid : official journal of the American Thyroid Association.

[332]  S. Yagel,et al.  Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. , 1998, American journal of obstetrics and gynecology.

[333]  S. Mizutani,et al.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. , 1998, Cancer research.

[334]  M. Klempner,et al.  Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis , 1998, Cancer.

[335]  R. Hughes,et al.  Matrix metalloproteinase expression during experimental autoimmune neuritis. , 1998, Brain : a journal of neurology.

[336]  S. Itohara,et al.  Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.

[337]  C. Koch,et al.  Studies of type IV collagenase regulation by hypoxia. , 1998, Cancer letters.

[338]  H. Chung,et al.  Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells , 1998, Oncogene.

[339]  A. Steere,et al.  Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. , 1998, The Journal of infectious diseases.

[340]  D. Goldenberg,et al.  Septic arthritis , 1998, The Lancet.

[341]  M. Stack,et al.  Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[342]  J. Uhm,et al.  Oligodendrocytes utilize a matrix metalloproteinase, MMP‐9, to extend processes along an astrocyte extracellular matrix , 1998, Glia.

[343]  H. E. Wart,et al.  Substrate Specificity and Mechanisms of Substrate Recognition of the Matrix Metalloproteinases , 1998 .

[344]  P. Proost,et al.  Interleukin-8 and other CXC chemokines , 1998 .

[345]  G. Amorino,et al.  Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. , 1998, The American journal of pathology.

[346]  R. Dwek,et al.  Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.

[347]  E. Huberman,et al.  Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. , 1998, The Journal of biological chemistry.

[348]  R. Cardiff,et al.  CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. , 1998, Journal of cellular physiology.

[349]  S. Barondes,et al.  X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. , 1998, The Journal of biological chemistry.

[350]  D. Fishman,et al.  Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. , 1998, Invasion & metastasis.

[351]  F. Lottspeich,et al.  Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. , 1998, Leukemia.

[352]  A. Reiner,et al.  Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. , 1998, Microvascular research.

[353]  U. Shankavaram,et al.  Regulation of human monocyte matrix metalloproteinases by SPARC , 1997, Journal of cellular physiology.

[354]  R. Fridman,et al.  Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.

[355]  B. C. Patterson,et al.  Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)* , 1997, The Journal of Biological Chemistry.

[356]  J. Voorhees,et al.  Pathophysiology of premature skin aging induced by ultraviolet light. , 1997, The New England journal of medicine.

[357]  Y. Sun,et al.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.

[358]  F. Orr,et al.  Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[359]  J. Bousquet,et al.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.

[360]  K. Yamada,et al.  Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. , 1997, Journal of immunology.

[361]  V. Perry,et al.  Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke , 1997, Neuropathology and applied neurobiology.

[362]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[363]  H. Chapman,et al.  Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.

[364]  J. Buhler,et al.  Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha. , 1997, The American journal of physiology.

[365]  J. Buhler,et al.  Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[366]  G. Tuszynski,et al.  Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. , 1997, Experimental cell research.

[367]  P. Libby,et al.  Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? , 1997, Circulation research.

[368]  C. López-Otín,et al.  Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). , 1997, European journal of biochemistry.

[369]  C. Wolf‐Peeters,et al.  Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. , 1997, The American journal of pathology.

[370]  G. Serio,et al.  Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. , 1997, European journal of cancer.

[371]  U. Bergmann,et al.  Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2* , 1997, The Journal of Biological Chemistry.

[372]  R. Bataille,et al.  Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. , 1997, Blood.

[373]  S. Spiegel,et al.  Calcium influx inhibits MT1‐MMP processing and blocks MMP‐2 activation , 1997, FEBS letters.

[374]  M. Grisham,et al.  Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. , 1997, The American journal of physiology.

[375]  J. Dequeker,et al.  Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. , 1997, British journal of rheumatology.

[376]  C. Overall,et al.  Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A , 1997, The Journal of Biological Chemistry.

[377]  H. Miyake,et al.  Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. , 1997, The Journal of urology.

[378]  G. Opdenakker,et al.  Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. , 1997, Cytokine.

[379]  R. Copeland,et al.  Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization. , 1997, Protein expression and purification.

[380]  P. Phillips,et al.  Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. , 1997, The American journal of physiology.

[381]  Kenneth M. Yamada,et al.  Modulation of MMP‐2 (gelatinase A) and MMP‐9 (gelatinase B) by interferon‐γ in a human salivary gland cell line , 1997, Journal of cellular physiology.

[382]  C. Bucana,et al.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.

[383]  J. Woessner,et al.  Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats. , 1997, Scandinavian journal of gastroenterology.

[384]  R. Muschel,et al.  Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line , 1997, Oncogene.

[385]  F. Kikkawa,et al.  c‐Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells , 1997, FEBS letters.

[386]  F. Thaiss,et al.  Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. , 1997, Kidney international.

[387]  R. Ohira,et al.  An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). , 1997, Biology of reproduction.

[388]  J. Garibay-Tupas,et al.  An autocrine/paracrine role of human decidual relaxin. I. Interstitial collagenase (matrix metalloproteinase-1) and tissue plasminogen activator. , 1997, Biology of reproduction.

[389]  J. Cossins,et al.  Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor , 1997, Journal of Neuroimmunology.

[390]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[391]  M. Cullen,et al.  Matrix Metalloproteinases in Dog Brains Exhibiting Alzheimer‐Like Characteristics , 1997, Journal of neurochemistry.

[392]  D. Falcone,et al.  Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression* , 1997, The Journal of Biological Chemistry.

[393]  E. Lengyel,et al.  Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades , 1997, Oncogene.

[394]  A. Aplin,et al.  Integrin-mediated Activation of MAP Kinase Is Independent of FAK: Evidence for Dual Integrin Signaling Pathways in Fibroblasts , 1997, The Journal of cell biology.

[395]  R. Fridman,et al.  Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells , 1997, International journal of cancer.

[396]  T. Vu,et al.  Gelatinase A Activation Is Regulated by the Organization of the Polymerized Actin Cytoskeleton* , 1997, The Journal of Biological Chemistry.

[397]  H. Emonard,et al.  Binding of 92 kDa and 72 kDa Progelatinases to Insoluble Elastin Modulates Their Proteolytic Activation , 1997, Biological chemistry.

[398]  U. Gullberg,et al.  Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development , 1997, European journal of haematology.

[399]  C. Brinckerhoff,et al.  The AP-1 site and MMP gene regulation: what is all the fuss about? , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[400]  T. Stephenson,et al.  Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. , 1997, Journal of immunology.

[401]  M. Belin,et al.  Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes , 1997, Molecular Psychiatry.

[402]  G. Opdenakker,et al.  Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. , 1997, European journal of biochemistry.

[403]  H. Kolkenbrock,et al.  Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix Metalloproteinase , 1997, Biological chemistry.

[404]  E. Canalis,et al.  Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post‐transcriptional mechanisms in osteoblast cultures , 1997 .

[405]  G. Ferry,et al.  Activation of MMP‐9 by neutrophil elastase in an in vivo model of acute lung injury , 1997, FEBS letters.

[406]  H. Sato,et al.  Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin , 1997, FEBS Letters.

[407]  D. Faller,et al.  Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. , 1997, Virology.

[408]  Y. Seyama,et al.  Anti‐α3 integrin antibody induces the activated form of matrix metalloprotease‐2 (MMP‐2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells , 1997, International journal of cancer.

[409]  B. Toole,et al.  Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells* , 1997, The Journal of Biological Chemistry.

[410]  Y. Kodera,et al.  Plasma concentration of matrix metalloproteinase 9 in gastric cancer , 1997, The British journal of surgery.

[411]  G. Sutton,et al.  Collagenase expression in ovarian cancer cell lines. , 1995, Gynecologic oncology.

[412]  R. Dwek,et al.  Glycosylation: heterogeneity and the 3D structure of proteins. , 1997, Critical reviews in biochemistry and molecular biology.

[413]  B. Zimmermann,et al.  Substance P Induces the Secretion of Gelatinase A from Human Synovial Fibroblasts , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[414]  N. Copeland,et al.  Matrix metalloproteinase-9 maps to the distal end of chromosome 2 in the mouse. , 1997, Developmental genetics.

[415]  Michael J. Cullen,et al.  Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40) , 1996, The Journal of Neuroscience.

[416]  J. Uhm,et al.  Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9 , 1996 .

[417]  G. Opdenakker,et al.  Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. , 1996, Cytometry.

[418]  E. Waubant,et al.  Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis , 1996, Annals of neurology.

[419]  G. Schultz,et al.  Tissue inhibitor of metalloproteinases‐3 is the major metalloproteinase inhibitor in the decidualizing murine uterus , 1996, Molecular reproduction and development.

[420]  J. Newcombe,et al.  The Expression of Tissue‐type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis: Comparison of Stages in Lesion Evolution , 1996, Journal of neuropathology and experimental neurology.

[421]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[422]  J. Harb,et al.  Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. , 1996, Cancer research.

[423]  D. Rappolee,et al.  Basement Membrane and Repair of Injury to Peripheral Nerve: Defining a Potential Role for Macrophages, Matrix Metalloproteinases, and Tissue Inhibitor of Metalloproteinases-1 , 1996, The Journal of experimental medicine.

[424]  B. Weeks,et al.  bFGF stimulates U937 cell adhesion to fibronectin and secretion of gelatinase B. , 1996, Biochemical and biophysical research communications.

[425]  P. Kovanen,et al.  TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. , 1996, Journal of immunology.

[426]  M. Lotze,et al.  Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4. , 1996, Cellular immunology.

[427]  J. Rubin,et al.  Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production* , 1996, The Journal of Biological Chemistry.

[428]  G. Nuovo,et al.  Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. , 1996, Arthritis and rheumatism.

[429]  N. Haites,et al.  Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. , 1996, European journal of cancer.

[430]  C. He,et al.  Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. , 1996, Cancer letters.

[431]  H. Sato,et al.  Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2 , 1996, FEBS letters.

[432]  S. Kapila,et al.  Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[433]  A. Koch,et al.  Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[434]  M. Takigawa,et al.  Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. , 1996, Endocrinology.

[435]  G. Rice,et al.  Pharmacological inhibition of gelatinase B induction and tumor cell invasion , 1996, International journal of cancer.

[436]  P. Suter,et al.  Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[437]  B. Mclaughlin,et al.  Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis. , 1996, The Biochemical journal.

[438]  C. López-Otín,et al.  Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.

[439]  E. Roets,et al.  The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. , 1996, Biochemical pharmacology.

[440]  C. Miller,et al.  Matrix Metalloproteinases in the Neocortex and Spinal Cord of Amyotrophic Lateral Sclerosis Patients , 1996, Journal of neurochemistry.

[441]  D. Hume,et al.  Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.

[442]  I. Zvibel,et al.  DISRUPTION OF CELL—CELL ADHESION IN THE PRESENCE OF SODIUM BUTYRATE ACTIVATES EXPRESSION OF THE 92kDa TYPE IV COLLAGENASE IN MDCK CELLS , 1996, Cell biology international.

[443]  S. Kumar,et al.  Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. , 1996, Journal of molecular and cellular cardiology.

[444]  J. Buhler,et al.  Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial Explants* , 1996, The Journal of Biological Chemistry.

[445]  S. Eccles,et al.  Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). , 1996, Cancer research.

[446]  Z. Gokaslan,et al.  Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin , 1996 .

[447]  C. Ford,et al.  Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis , 1996, Neurology.

[448]  M. Flannery,et al.  Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.

[449]  P. Kiener,et al.  Activation of human monocytes through CD40 induces matrix metalloproteinases. , 1996, Journal of immunology.

[450]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[451]  D. Woolley,et al.  Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. , 1996, Journal of reproduction and fertility.

[452]  Gary A. Rosenberg,et al.  Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[453]  A. Vaheri,et al.  Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. , 1996, The Journal of investigative dermatology.

[454]  N. Seidah,et al.  Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. , 1996, The Biochemical journal.

[455]  G. Opdenakker,et al.  Gelatinase A secretion and its control in peritubular and Sertoli cell cultures: effects of hormones, second messengers and inducers of cytokine production , 1996, Molecular and Cellular Endocrinology.

[456]  K. Somasundaram,et al.  Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[457]  P. Gottschall,et al.  Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides , 1996 .

[458]  J. Strauss,et al.  Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. , 1996, American journal of obstetrics and gynecology.

[459]  L. Windsor,et al.  Activation of human progelatinase A by collagenase and matrilysin: Activation of procollagenase by matrilysin , 1996, Journal of protein chemistry.

[460]  S. Lazarus,et al.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.

[461]  Y. Okada,et al.  Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co‐culture of human osteosarcoma cells and human fibroblasts: Gelatinase‐B production was stimulated via up‐regulation of fibroblast growth factor (FGF) receptor , 1996, International journal of cancer.

[462]  H. Flad,et al.  TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. , 1996, Journal of immunology.

[463]  A. Yuo,et al.  Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. , 1996, Experimental hematology.

[464]  R. Sobel,et al.  Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions , 1996, Journal of neuropathology and experimental neurology.

[465]  C. Delacourt,et al.  Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.

[466]  W. Rom,et al.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. , 1996, Thorax.

[467]  Y. Okada,et al.  Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas , 1996, International journal of cancer.

[468]  I. Hewlett,et al.  HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.

[469]  W. Couser,et al.  Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. , 1996, The Journal of clinical investigation.

[470]  G. Opdenakker,et al.  Synergistic and selective stimulation of gelatinase B production in macrophages by lipopolysaccharide, trans-retinoic acid and CGP 41251, a protein kinase C regulator. , 1996, Biochimica et biophysica acta.

[471]  G. Nuovo,et al.  Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. , 1996, Clinical immunology and immunopathology.

[472]  J. Zahm,et al.  Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium , 1996, Journal of cellular physiology.

[473]  M. Seiki,et al.  Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. , 1996, The American journal of pathology.

[474]  S. Zucker,et al.  Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[475]  P. Singhal,et al.  Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. , 1996, Biochemical and biophysical research communications.

[476]  J. Voorhees,et al.  Molecular basis of sun-induced premature skin ageing and retinoid antagonism , 1996, Nature.

[477]  B. Nielsen,et al.  92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer , 1996, International journal of cancer.

[478]  K. Takeda,et al.  Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion. , 1996, Cancer letters.

[479]  M. Kitamura,et al.  Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. , 1996, The American journal of physiology.

[480]  Schroen Dj,et al.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996 .

[481]  L. Matrisian,et al.  Complex roles of matrix metalloproteinases in tumor progression. , 1996, Current topics in microbiology and immunology.

[482]  T. Sato,et al.  Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNFalpha. , 1996, FEBS letters.

[483]  V. Leblond,et al.  Production of type IV collagen and 72-kDa gelatinase by human endothelial cells cultured in high glucose. Effects of a protein kinase C inhibitor, GF 109203X. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[484]  S. Hauser,et al.  Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.

[485]  T. Haas,et al.  The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[486]  W. Stetler-Stevenson,et al.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.

[487]  J. Uhm,et al.  Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. , 1996, Clinical & experimental metastasis.

[488]  M. Reidy,et al.  Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.

[489]  W. T. Chen,et al.  A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. , 1996, The Journal of biological chemistry.

[490]  Z. Gokaslan,et al.  Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. , 1996, Cancer letters.

[491]  G. Murphy,et al.  Activation of human neutrophil procollagenase by stromelysin 2. , 1996, European journal of biochemistry.

[492]  William G. Stetler-Stevenson,et al.  Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window , 1995, Brain Research.

[493]  G. Opdenakker,et al.  Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. , 1995, European journal of biochemistry.

[494]  J. Dayer,et al.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.

[495]  C. Delacourt,et al.  Tachykinins induce gelatinase production by guinea pig alveolar macrophages: involvement of NK2 receptors. , 1995, The American journal of physiology.

[496]  S. Hauser,et al.  Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[497]  Y. Watanabe,et al.  Characterization of gelatinases in human placenta. , 1995, Biochemical and molecular medicine.

[498]  Hiroshi Sato,et al.  Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.

[499]  I. Pucci‐Minafra,et al.  Cell‐cell and cell‐collagen interactions influence gelatinase production by human breast‐carcinoma cell line 8701‐BC , 1995, International journal of cancer.

[500]  R. Kerbel,et al.  The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. , 1995, Cancer research.

[501]  H. Birkedal‐Hansen,et al.  Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. , 1995, Biochimica et biophysica acta.

[502]  R. Muschel,et al.  MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. , 1995, Brain research. Developmental brain research.

[503]  J. Gershenwald,et al.  Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. , 1995, Cancer research.

[504]  A. Pollock,et al.  Tissue-specific Enhancer-Promoter Interactions Regulate High Level Constitutive Expression of Matrix Metalloproteinase 2 by Glomerular Mesangial Cells (*) , 1995, The Journal of Biological Chemistry.

[505]  H. Friess,et al.  Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer , 1995, International journal of cancer.

[506]  Y. Itoh,et al.  Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*) , 1995, The Journal of Biological Chemistry.

[507]  T. Pourmotabbed,et al.  Mechanism of Activation of Human Neutrophil Gelatinase B , 1995, The Journal of Biological Chemistry.

[508]  J. Strauss,et al.  92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. , 1995, Biology of reproduction.

[509]  J. Furuyama,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. , 1995, Journal of neurosurgery.

[510]  C. Delacourt,et al.  Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[511]  L. Cornelius,et al.  Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. , 1995, The Journal of investigative dermatology.

[512]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[513]  W. Pearce,et al.  In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[514]  H. Sato,et al.  Complex Regulation of Membrane-type Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation by Concanavalin a in Mda-mb-231 Human Breast Cancer Cells1 Activation of Which Has Been Associated with Metastatic Progression in Human Breast Cancer (hbc). Concanavalin a (con A) Has Be , 2022 .

[515]  M. J. Banda,et al.  Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. , 1995, Biochemistry.

[516]  P. Barker,et al.  Binding of gelatinases A and B to type-I collagen and other matrix components. , 1995, The Biochemical journal.

[517]  Y. Ito,et al.  Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. , 1995, Cancer research.

[518]  U. Puistola,et al.  Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. , 1995, Fertility and sterility.

[519]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[520]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[521]  R. Fridman,et al.  Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). , 1995, Cancer research.

[522]  D. Faller,et al.  The Moloney Leukemia Retroviral Long Terminal Repeat trans-Activates AP-1-inducible Genes and AP-1 Transcription Factor Binding (*) , 1995, The Journal of Biological Chemistry.

[523]  R. Kerbel,et al.  Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. , 1995, Experimental cell research.

[524]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[525]  H. Kleinman,et al.  Laminin SIKVAV Peptide Induction of Monocyte/Macrophage Prostaglandin E and Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.

[526]  E. Waubant,et al.  T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.

[527]  B. Verrier,et al.  Induction of MMP9 (92 kDa Gelatinase) Activity and Expression of Tissue In hibitor of Metalloproteinase‐2 mRNA (TIMP‐2) in Primitive Neuroectodermal Cells Infected with Retrovirus HTLV‐I , 1995, The European journal of neuroscience.

[528]  Z. Werb,et al.  Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin , 1995, The Journal of cell biology.

[529]  J. Isner,et al.  Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.

[530]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[531]  T. Noumi,et al.  Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.

[532]  B. Olsen,et al.  92‐kDa type IV collagenase and TIMP‐3, but not 72‐kDa type IV collagenase or TIMP‐1 or TIMP‐2, are highly expressed during mouse embryo implantation , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[533]  W. Rath,et al.  Biochemical events in cervical ripening dilatation during pregnancy and parturition. , 1995, Journal of obstetrics and gynaecology.

[534]  G. Schultz,et al.  Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. , 1995, Development.

[535]  S. De Flora,et al.  Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N‐acetylcysteine , 1995, International journal of cancer.

[536]  K. Imai,et al.  Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells , 1995, The Journal of Biological Chemistry.

[537]  R. Mecham,et al.  Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate , 1995, The Journal of Biological Chemistry.

[538]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[539]  F. Breedveld,et al.  Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. , 1995, The Journal of rheumatology.

[540]  L. Mahadevan,et al.  Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.

[541]  Z. Tökés,et al.  The 84‐kDa Form of Human Matrix Metalloproteinase‐9 Degrades Substance P and Gelatin , 1995, Journal of neurochemistry.

[542]  M. Longaker,et al.  Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. , 1995, The Journal of investigative dermatology.

[543]  H. Baylis,et al.  Infection with Theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes. , 1995, Molecular and biochemical parasitology.

[544]  F. Kikkawa,et al.  Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. , 1995, American journal of obstetrics and gynecology.

[545]  D. Steed,et al.  Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease , 1995, Annals of human genetics.

[546]  S. Shapiro,et al.  Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis. , 1995, The Journal of investigative dermatology.

[547]  Y. Okada,et al.  Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[548]  G Murphy,et al.  Tissue inhibitors of matrix metalloendopeptidases. , 1995, Methods in enzymology.

[549]  H. Tschesche Human neutrophil collagenase. , 1995, Methods in enzymology.

[550]  E. Furth,et al.  92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. , 1995, The American journal of pathology.

[551]  J. Foidart,et al.  Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts. , 1995, Invasion & metastasis.

[552]  M. Yoshida,et al.  Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. , 1995, Journal of inflammation.

[553]  H. Schnaper,et al.  HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. , 1995, Journal of immunology.

[554]  K. Suzuki,et al.  Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. , 1995, The Biochemical journal.

[555]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[556]  S. Shapiro,et al.  Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. , 1994, American journal of respiratory and critical care medicine.

[557]  L. Steinman,et al.  Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.

[558]  L. Liotta,et al.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. , 1994, Biochemistry.

[559]  D. Dormont,et al.  Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures. , 1994, Biochemical and biophysical research communications.

[560]  F. Grinnell,et al.  Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. , 1994, The Journal of investigative dermatology.

[561]  M. Ågren,et al.  Gelatinase activity during wound healing , 1994, The British journal of dermatology.

[562]  R. Senior,et al.  Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. , 1994, Biochemical and biophysical research communications.

[563]  R. Sepper,et al.  Gelatinolytic and type IV collagenolytic activity in bronchiectasis. , 1994, Chest.

[564]  J. Dayer,et al.  Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. , 1994, The Journal of biological chemistry.

[565]  C. Azuma,et al.  Type‐IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues , 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[566]  G. Opdenakker,et al.  Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases , 1994, Journal of Neuroimmunology.

[567]  L. Liotta,et al.  Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[568]  J. Knowlden,et al.  Identification and independent regulation of human mesangial cell metalloproteinases. , 1994, Kidney international.

[569]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[570]  W. Stetler-Stevenson,et al.  Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. , 1994, The Journal of biological chemistry.

[571]  A. H. Drummond,et al.  Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.

[572]  T. Turpeenniemi‐Hujanen,et al.  Modulation of Mr 72,000 and Mr 92,000 type‐IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma , 1994, International journal of cancer.

[573]  T. Tsuruo,et al.  Human recombinant interferons‐beta and ‐gamma decrease gelatinase production and invasion by human KG‐2 renal‐carcinoma cells , 1994, International journal of cancer.

[574]  H. Larjava,et al.  Matrix Metalloproteinases (MMP-2 and MMP-9) of the Oral Cavity: Cellular Origin and Relationship to Periodontal Status , 1994, Journal of dental research.

[575]  D. Eyre,et al.  A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. , 1994, Biochemical and biophysical research communications.

[576]  P. Kovanen,et al.  Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. , 1994, The Journal of biological chemistry.

[577]  S. Martin,et al.  Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin. , 1994, The Journal of biological chemistry.

[578]  G. Zeng,et al.  Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts. , 1994, Experimental cell research.

[579]  Y. Soini,et al.  72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[580]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[581]  P. Petrides,et al.  Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. , 1994, Blood.

[582]  A. M. Romanic,et al.  The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent , 1994, The Journal of cell biology.

[583]  J. O'Connell,et al.  Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. , 1994, The Journal of biological chemistry.

[584]  J. O'Connell,et al.  Human progelatinase A can be activated by matrilysin , 1994, FEBS letters.

[585]  S. Gruber,et al.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[586]  M A Moses,et al.  Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.

[587]  W. Parks,et al.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.

[588]  C. Bucana,et al.  Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. , 1994, American Journal of Pathology.

[589]  W. Stetler-Stevenson,et al.  Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. , 1994, Archives of biochemistry and biophysics.

[590]  A. Clowes,et al.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. , 1994, The Journal of clinical investigation.

[591]  W. Stetler-Stevenson,et al.  Quantitative zymography: detection of picogram quantities of gelatinases. , 1994, Analytical biochemistry.

[592]  W. Stetler-Stevenson,et al.  Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[593]  I. Fidler,et al.  Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. , 1994, Journal of immunology.

[594]  R. Poorman,et al.  Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.

[595]  M. Cockett,et al.  Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. , 1994, The Journal of biological chemistry.

[596]  J. Dayer,et al.  1,25-dihydroxyvitamin D3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes. , 1994, The Journal of biological chemistry.

[597]  C. Munaut,et al.  High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development , 1994, The Journal of cell biology.

[598]  I. Lubensky,et al.  Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. , 1994, The American journal of pathology.

[599]  R. Huber,et al.  The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. , 1994, The EMBO journal.

[600]  G. Opdenakker,et al.  Cytokine-regulated proteases in autoimmune diseases. , 1994, Immunology today.

[601]  R. Eckert,et al.  Transforming Growth Factor β1 Regulation of Metalloproteinase Production in Cultured Human Cervical Epithelial Cells , 1994 .

[602]  C. Bucana,et al.  Regulation of Gelatinase Production in Metastatic Renal Cell Carcinoma by Organ‐specific Fibroblasts , 1994, Japanese journal of cancer research : Gann.

[603]  H. Larjava,et al.  Expression of matrix metalloproteinase-2 and -9 during early human wound healing. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[604]  E. Amento,et al.  Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. , 1994, Experimental cell research.

[605]  C. Bailey,et al.  Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. , 1994, Journal of clinical pathology.

[606]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[607]  L. Liotta,et al.  Induction of tissue‐type plasminogen activator and 72‐kDa type‐IV collagenase by ionizing radiation in rat astrocytes , 1994, International journal of cancer.

[608]  E. Lehtonen,et al.  Increased expression of the matrix metalloproteinase 2 in differentiating tera 2 human embryonal carcinoma cells , 1994, International journal of cancer.

[609]  R. Rees,et al.  Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. , 1994, British Journal of Cancer.

[610]  R. Muschel,et al.  Metalloproteinases in tumor progression: the contribution of MMP-9. , 1994, Invasion & metastasis.

[611]  M. Stearns,et al.  Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. , 1994, Oncology research.

[612]  D. Lovett,et al.  Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. , 1994, The American journal of pathology.

[613]  R. Eckert,et al.  Transforming Growth Factor 131 Regulation of Metalloproteinase Production in Cultured Human Cervical Epithelial Cells , 2007 .

[614]  V. V. van Hinsbergh,et al.  Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.

[615]  E. Bock,et al.  Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[616]  H. Schnaper,et al.  Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B) , 1993, Journal of cellular physiology.

[617]  C. Soria,et al.  Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.

[618]  C. Ioannou,et al.  Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. , 1993, European journal of biochemistry.

[619]  C. Figdor,et al.  Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. , 1993, Journal of immunology.

[620]  A. Hanby,et al.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.

[621]  H. Sato,et al.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.

[622]  G. Opdenakker,et al.  Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein , 1993, Journal of neuroscience research.

[623]  G. Opdenakker,et al.  Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. , 1993, European journal of biochemistry.

[624]  P. Roughley,et al.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.

[625]  Y. DeClerck,et al.  Direct activation of human neutrophil procollagenase by recombinant stromelysin. , 1993, The Biochemical journal.

[626]  H. Birkedal‐Hansen,et al.  Anti‐integrin antibodies induce type IV collagenase expression in keratinocytes , 1993, Journal of cellular physiology.

[627]  T. Salo,et al.  Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[628]  Y. Tomino,et al.  Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F1 mice. , 1993, Clinical science.

[629]  G. Nicolson,et al.  Role and regulation of expression of 92‐kDa type‐IV collagenase (MMP‐9) in 2 invasive squamous‐cell‐carcinoma cell lines of the oral cavity , 1993, International journal of cancer.

[630]  W. Parks,et al.  Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. , 1993, The Journal of biological chemistry.

[631]  H. Birkedal‐Hansen,et al.  Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. , 1993, The Journal of biological chemistry.

[632]  H. Schnaper,et al.  Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro , 1993, Journal of cellular physiology.

[633]  T. Salo,et al.  Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. , 1993, The Journal of investigative dermatology.

[634]  Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. , 1993, Cancer research.

[635]  F. Grinnell,et al.  Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.

[636]  W. Stetler-Stevenson,et al.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. , 1993, The Journal of clinical investigation.

[637]  H. Birkedal‐Hansen,et al.  Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). , 1993, Biochemistry.

[638]  H. Zhou,et al.  Induction of metalloproteinase activity in human T-lymphocytes. , 1993, Biochimica et biophysica acta.

[639]  W. Stetler-Stevenson,et al.  HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. , 1993, AIDS research and human retroviruses.

[640]  J. Rhim,et al.  Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes. , 1993, Biochemical and biophysical research communications.

[641]  H. Sengeløv,et al.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.

[642]  L. Liotta,et al.  Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors , 1993 .

[643]  S. Wahl,et al.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[644]  G. Opdenakker,et al.  Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. , 1993, Biochemical and biophysical research communications.

[645]  Wahl Lm,et al.  REGULATION OF MONOCYTE/MACROPHAGE METALLOPROTEINASE PRODUCTION BY CYTOKINES , 1993 .

[646]  H. Sabzevari,et al.  Production and regulation of gelatinase B by human T-cells. , 1993, Biochimica et biophysica acta.

[647]  S. Shapiro,et al.  Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. , 1993, The Journal of biological chemistry.

[648]  D. Lovett,et al.  Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. , 1993, The Biochemical journal.

[649]  J. Hoidal,et al.  Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. , 1993, The Journal of clinical investigation.

[650]  Y. Okada,et al.  Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. , 1993, Journal of cell science.

[651]  Y. Sasaguri,et al.  Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. , 1993, British Journal of Cancer.

[652]  L. Kjeldsen,et al.  Control of exocytosis in early neutrophil activation. , 1993, Journal of immunology.

[653]  H. Tanaka,et al.  Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[654]  H. Sato,et al.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.

[655]  C. Wolf‐Peeters,et al.  Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. , 1993, Journal of immunology.

[656]  M. Ingelman-Sundberg,et al.  Differential regulation of gelatinase b and tissue‐type plasminogen activator expression in human bowes melanoma cells , 1993, International journal of cancer.

[657]  A. Eisen,et al.  Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. , 1993, The Journal of investigative dermatology.

[658]  L. Wahl,et al.  Regulation of monocyte/macrophage metalloproteinase production by cytokines. , 1993, Journal of periodontology.

[659]  U. Moll,et al.  Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .

[660]  V. Castronovo,et al.  Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. , 1993, Invasion & metastasis.

[661]  M. Hendrix,et al.  The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. , 1993, Cancer research.

[662]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[663]  A. Kossakowska,et al.  Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. , 1993, Oncology research.

[664]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[665]  H. Tschesche,et al.  A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase , 1992, FEBS letters.

[666]  P. Courtoy,et al.  Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[667]  J. Lohi,et al.  Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin , 1992, Journal of cellular biochemistry.

[668]  Y. Takada,et al.  VLA‐4 Molecules on Tumor Cells Initiate an Adhesive Interaction with VCAM‐1 Molecules on Endothelial Cell Surface , 1992, Japanese journal of cancer research : Gann.

[669]  C. Bucana,et al.  Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. , 1992, Differentiation; research in biological diversity.

[670]  G. Goldberg,et al.  Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. , 1992, The Journal of investigative dermatology.

[671]  S Bord,et al.  Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. , 1992, Journal of cell science.

[672]  G. Opdenakker,et al.  Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders , 1992, Journal of Neuroimmunology.

[673]  K. Naka,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.

[674]  W. Stetler-Stevenson,et al.  Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast‐cancer cells , 1992, International journal of cancer.

[675]  L. Kjeldsen,et al.  Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. , 1992, The Biochemical journal.

[676]  T. Hardingham,et al.  The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. , 1992, The Journal of biological chemistry.

[677]  H. Flad,et al.  Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. , 1992, Journal of immunology.

[678]  R. Ulrich,et al.  Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor. , 1992, Clinical immunology and immunopathology.

[679]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[680]  M. Meltzer,et al.  Interactions between HIV‐infected monocytes and the extracellular matrix: HIV‐infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices , 1992, Journal of leukocyte biology.

[681]  Y. Sasaguri,et al.  Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.

[682]  G. Opdenakker,et al.  Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. , 1992, Cytokine.

[683]  C. Azuma,et al.  Malignant cell‐specific gelatinase activity in human endometrial carcinoma , 1992, Cancer.

[684]  C. Hack,et al.  Interleukin-8 in sepsis: relation to shock and inflammatory mediators , 1992, Infection and immunity.

[685]  M. Stearns,et al.  Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. , 1992, Cancer research.

[686]  N. Koshikawa,et al.  Activation of TIMP-2/progelatinase A complex by stromelysin. , 1992, Biochemical and biophysical research communications.

[687]  Y. Kato,et al.  Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. , 1992, The Journal of biological chemistry.

[688]  G. N. Smith,et al.  Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. , 1992, The Journal of rheumatology.

[689]  A. Strongin,et al.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.

[690]  M. Hendrix,et al.  Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[691]  T. Hurskainen,et al.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.

[692]  J. Enghild,et al.  Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. , 1992, The Journal of biological chemistry.

[693]  H. Tschesche,et al.  Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase) , 1992, FEBS letters.

[694]  K. Iwata,et al.  Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.

[695]  J. Delaissé,et al.  Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases , 1992, Journal of cellular physiology.

[696]  R. Colman,et al.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. , 1992, The Journal of laboratory and clinical medicine.

[697]  Z. Werb,et al.  Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. , 1992, Development.

[698]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[699]  W. Stetler-Stevenson,et al.  Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. , 1992, The Journal of biological chemistry.

[700]  U. Thorgeirsson,et al.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.

[701]  H. Sato,et al.  Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. , 1992, Oncogene.

[702]  T. Hurskainen,et al.  70 K type IV collagenase (gelatinase). , 1992, Matrix (Stuttgart, Germany). Supplement.

[703]  G. Opdenakker,et al.  Chemotactic factors, passive invasion and metastasis of cancer cells. , 1992, Immunology today.

[704]  W. Stetler-Stevenson,et al.  Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. , 1991, Cancer research.

[705]  M. Kuwano,et al.  The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors , 1991, International journal of cancer.

[706]  E. Amento,et al.  Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. , 1991, The Journal of clinical investigation.

[707]  M. Matsubara,et al.  Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. , 1991, Developmental biology.

[708]  A. Eisen,et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.

[709]  L. Chow,et al.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. , 1991, The Journal of biological chemistry.

[710]  W. Stetler-Stevenson,et al.  Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture. , 1991, Biology of reproduction.

[711]  R. Williamson,et al.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.

[712]  V. Lefebvre,et al.  Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. , 1991, Biochimica et biophysica acta.

[713]  G. Opdenakker,et al.  Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. , 1991, Lymphokine and cytokine research.

[714]  J. Wrana,et al.  Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.

[715]  E. Howard,et al.  Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.

[716]  H. Birkedal‐Hansen,et al.  Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. , 1991, The Journal of biological chemistry.

[717]  G. Opdenakker,et al.  Natural human monocyte gelatinase and its inhibitor , 1991, FEBS letters.

[718]  G. Opdenakker,et al.  Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.

[719]  L. Moldawer,et al.  IL-8 in septic shock, endotoxemia, and after IL-1 administration. , 1991, Journal of immunology.

[720]  J. Auwerx,et al.  The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers. , 1991, Cytokine.

[721]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[722]  R. Fridman,et al.  Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease , 1991 .

[723]  S. Shapiro,et al.  Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.

[724]  Z. Werb,et al.  92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.

[725]  F. Blasi,et al.  Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.

[726]  S. Maśliński,et al.  Activation of the latent human neutrophil gelatinase by urea. , 1991, Acta biochimica Polonica.

[727]  L. Liotta,et al.  Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.

[728]  U. Thorgeirsson,et al.  Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. , 1990, The Journal of biological chemistry.

[729]  L. Chow,et al.  Structure and expression of type IV collagenase genes. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[730]  C. Overall,et al.  Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.

[731]  S. Frisch,et al.  Positive and negative transcriptional elements of the human type IV collagenase gene , 1990, Molecular and cellular biology.

[732]  A Yasui,et al.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.

[733]  K. Suzuki,et al.  Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). , 1990, Biochemistry.

[734]  A. Eisen,et al.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.

[735]  S. Shapiro,et al.  Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. , 1990, The Journal of clinical investigation.

[736]  U. Moll,et al.  Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. , 1990, Cancer research.

[737]  L. Liotta,et al.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. , 1990, Cancer research.

[738]  G. Opdenakker,et al.  Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. , 1990, Biochimica et biophysica acta.

[739]  Y. Okada,et al.  Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. , 1990, Biochemical and biophysical research communications.

[740]  J. P. Thompson,et al.  Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. , 1990, The Journal of biological chemistry.

[741]  L. Chow,et al.  Structure of the human type IV collagenase gene. , 1990, The Journal of biological chemistry.

[742]  B. Wasylyk,et al.  The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.

[743]  R. Muschel,et al.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. , 1990, Cancer research.

[744]  H. Birkedal‐Hansen,et al.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[745]  K. Suzuki,et al.  Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. , 1990, Biochemistry.

[746]  Andre Scedrov,et al.  Functional polymorphism , 1990 .

[747]  L. Wahl,et al.  Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production. , 1990, Journal of immunology.

[748]  L. Matrisian,et al.  TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence , 1990, Cell.

[749]  J. McKerrow,et al.  Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. , 1990, Cancer research.

[750]  H. Tschesche,et al.  Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. , 1990, European journal of biochemistry.

[751]  R. Eddy,et al.  Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. , 1990, Genomics.

[752]  H. M. Lee,et al.  The effect of phenytoin on collagenase and gelatinase activities in UMR 106-01 rat osteoblastic osteosarcoma cells. , 1990, Matrix.

[753]  H. Kleinman,et al.  Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[754]  B. Martin,et al.  Differentiation of HL-60 Promyelocytic Leukemia Cells: A Member of the Collagenase Family of Enzymes , 1990 .

[755]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[756]  S. Frisch,et al.  Secreted Proteases , 1990 .

[757]  J. Lacal,et al.  Differential effects of phorbol ester on the in vitro invasiveness of malignant and non‐malignant human fibroblast cells , 1990, Journal of cellular physiology.

[758]  D. Schurman,et al.  Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. , 1990, Arthritis and rheumatism.

[759]  S. Frisch,et al.  Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. , 1990, Oncogene.

[760]  K. Suzuki,et al.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. , 1989, The Journal of clinical investigation.

[761]  A. Eisen,et al.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.

[762]  G. Zhang,et al.  Adhesive and degradative properties of human placental cytotrophoblast cells in vitro , 1989, The Journal of cell biology.

[763]  Z. Werb,et al.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.

[764]  R. Nicholson,et al.  Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. , 1989, Biochemistry.

[765]  Y. Okada,et al.  Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G , 1989, FEBS letters.

[766]  H. Nakagawa,et al.  Activation by cathepsin G of latent gelatinase secreted from rat polymorphonuclear leukocytes. , 1989, Chemical & pharmaceutical bulletin.

[767]  M. Hendrix,et al.  Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. , 1989, Cancer research.

[768]  J. Wrana,et al.  Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. , 1989, Connective tissue research.

[769]  L. Liotta,et al.  Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts. , 1988, Journal of the National Cancer Institute.

[770]  D. Gomez,et al.  Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. , 1988, Biochemical and biophysical research communications.

[771]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[772]  R. Rees,et al.  Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts. , 1988, British Journal of Cancer.

[773]  J. van Beeumen,et al.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.

[774]  R. Dwek,et al.  Glycobiology , 2018, Biochimie.

[775]  A. Kang,et al.  Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. , 1987, The Journal of clinical investigation.

[776]  M. Karin,et al.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP , 1987, Cell.

[777]  L. Lund,et al.  Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells , 1987, Molecular and cellular biology.

[778]  L. Ala‐Kokko,et al.  Dexamethasone modulates the metabolism of type IV collagen and fibronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells. , 1987, The Biochemical journal.

[779]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[780]  L. Liotta,et al.  Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.

[781]  H. Nakagawa,et al.  Partial purification and characterization of exudate gelatinase in the acute phase of carrageenin-induced inflammation in rats. , 1986, Journal of biochemistry.

[782]  S. Weiss,et al.  Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[783]  L. Liotta,et al.  Laminin increases the release of type IV collagenase from malignant cells. , 1986, The Journal of biological chemistry.

[784]  J. Uitto,et al.  Glucocorticoid action on connective tissue: from molecular mechanisms to clinical practice. , 1986, Medical biology.

[785]  P. Stephens,et al.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.

[786]  Y. Nishizuka The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.

[787]  M. Jochum,et al.  Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. , 1984, Advances in experimental medicine and biology.

[788]  J. Uitto,et al.  Proteinases in Human Polymorphonuclear Leukocytes , 1983 .

[789]  P. Roche,et al.  Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. , 1983, Biochimica et biophysica acta.

[790]  J. Uitto,et al.  Proteinases in human polymorphonuclear leukocytes. Purification and characterization of an enzyme which cleaves denatured collagen and a synthetic peptide with a Gly-Ile sequence. , 1983, European journal of biochemistry.

[791]  C. Brosnan,et al.  Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis , 1980, Nature.

[792]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[793]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[794]  G. Vaes,et al.  Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.

[795]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.

[796]  W. Mcdonald,et al.  Leucocyte proteinase activity and acute multiple sclerosis , 1975, Journal of Neurological Sciences.

[797]  S. Krane,et al.  An endopeptidase from rheumatoid synovial tissue culture. , 1972, Biochimica et biophysica acta.

[798]  W. Wooster,et al.  Crystal structure of , 2005 .